Clinical trial · Observational
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734CI-TRIAL-00108587active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the effect of bladder cancer treatment on quality of life.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stage 0a Bladder Cancer AJCC v8 | Malignant Bladder Neoplasm | CURATED_BROADER | 0.78 |
| Stage 0is Bladder Cancer AJCC v8 | Malignant Bladder Neoplasm | CURATED_BROADER | 0.78 |
| Stage I Bladder Cancer AJCC v8 | Malignant Bladder Neoplasm | CURATED_BROADER | 0.78 |
| Stage II Bladder Cancer AJCC v8 | Malignant Bladder Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIA Bladder Cancer AJCC v8 | Malignant Bladder Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-Interventional Study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational
- description
- Patients complete surveys and also have their medical records reviewed on study.
- interventionNames
- Other: Non-Interventional Study
Primary outcomes (3)
- measure
- Change in quality of life outcomes - PROMIS-29
- timeFrame
- At baseline, 6, 12, 24, and 36 months
- description
- Assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS)-29, a 29-item instrument with 29 questions in eight categories of Health Related Quality of Life (HRQOL): physical function, sleep disturbance, pain interference and pain intensity, fatigue, anxiety, depression) and ability to participate in social roles and activities. Questions are answered on a 5-point scale with varying responses assigned to the scale based on the category/question.
- measure
- Change in quality of life outcomes - Bladder Cancer Index
- timeFrame
- At baseline, 6, 12, 24, and 36 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Have pathologically confirmed, clinically localized, bladder cancer * Be willing to complete a survey in English before starting definitive treatment (surgery or radiation); * Able to give consent. Exclusion Criteria: * Does not meet inclusion criteria
References
Publications (0)
Data not yet available
No reference posted for this study.